Wordt geladen...
Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
OBJECTIVE: Arformoterol is the (R,R)-enantiomer of formoterol. Preclinical studies suggest that it is a stronger bronchodilator than the racemic (R,R/S,S)-formoterol; however, its potential clinical advantages have not been demonstrated. This study compared the length of stay (LOS), 30-day readmissi...
Bewaard in:
| Gepubliceerd in: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490469/ https://ncbi.nlm.nih.gov/pubmed/28694692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S134145 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|